Potential associations between RANKL, OPG and NAFLD have been investigated, with experimental data showing that the hepatic expression of RANKL may be elevated in patients with NAFLD (44). This evidence concerns the gene TNFSF11 and metabolic dysfunction-associated steatotic liver disease.